Table 2. Response of preoperative chemotherapy and surgery resection rate in the two groups (N = 242).

	EOX (group A; N = 112) No. of patients (%)	XELOX(group B; N = 130) No. of patients (%)	P value
Response evaluation
CR	1/112 (0.9)	2/130 (1.5)	0.378
PR	36/112 (32.1)	42/130 (32.3)
SD	56/112 (50.0)	71/130 (54.6)
PD	19/112 (17.0)	14/130 (10.8)
Not assessable	0/112 (0)	1/130* (0.8)
RR (CR plus PR)	37/112 (33.0)	44/130 (33.8)	0.997
DCR (CR plus RR plus SD)	93/112 (83.0)	115/130 (88.4)	0.305
Patients received surgery
Radical surgery	63/112 (56.3)	81/130 (62.3)	0.408
Palliative surgery	19/112 (17.0)	9/130 (6.9)
No surgery	30/112 (26.7)	40/130 (30.8)

^*One did not have response evaluation because of acute stomach perforation five days after the first cycle of chemotherapy. CR complete response PR partial response SD stable response PD progression of disease RR response rate DCR disease control rate